Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable metho...
Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy
About this item
Full title
Author / Creator
Alten, R E , Zerbini, C , Jeka, S , Irazoque, F , Khatib, F , Emery, P , Bertasso, A , Rabbia, M and Caulfield, J P
Publisher
London: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Objective:To determine the efficacy and safety of pamapimod in adult patients with active rheumatoid arthritis (RA) who had an inadequate clinical response to methotrexate (MTX).Methods:Patients receiving stable doses of MTX were randomised to one of six dose groups and received 12 weeks of double-blind pamapimod (up to 300 mg once daily) or matchi...
Alternative Titles
Full title
Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1777858231
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777858231
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/ard.2008.104802
